Objective: To observe the efficacy of Shenfu Injection (SHF) decreasing the toxicities and improving the quality of life in the patients with advanced Non-Small Cell Lung Cancer (NSCLC) with Taxol plus Cisplatin(TP) or Vinorelbine plus Cisplatin(NP).

• 目的 分别观察参附注射液(SHF)对TP/NP两化疗方案治疗非小细胞肺癌(NSCLC)患者过程中的减毒作用和生活质量变化的影响。